Showing results (291-300 of 969) with videos related to
Sort By:
Pageof 97
Clinical Lymphoma, Myeloma & Leukemia|September 20, 2023
Early Mortality as a Quality Indicator in Frontline and Salvage Acute Myeloid LeukemiaKoji Sasaki, Farhad Ravandi, Courtney DiNardo, et al.Expert Review of Anticancer Therapy|March 13, 2015
The role of ponatinib in Philadelphia chromosome-positive acute lymphoblastic leukemiaDavid S Sanford, Hagop Kantarjian, Susan O'Brien, et al.Current Oncology Reports|June 14, 2021
Current Approaches to Philadelphia Chromosome-Positive B-Cell Lineage Acute Lymphoblastic Leukemia: Role of Tyrosine Kinase Inhibitor and Stem Cell TransplantKunhwa Kim, Elias Jabbour, Nicholas J Short, et al.Cancer|October 24, 2007
Potential cure of acute myeloid leukemia : analysis of 1069 consecutive patients in first complete remissionMasamitsu Yanada, Guillermo Garcia-Manero, Gautam Borthakur, et al.Cancer|August 23, 2008
Results of the hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimen in elderly patients with acute lymphocytic leukemiaSusan O'Brien, Deborah A Thomas, Farhad Ravandi, et al.Therapeutic Advances in Hematology|June 18, 2019
Novel monoclonal antibody-based treatment strategies in adults with acute lymphoblastic leukemiaVeronica A Guerra, Elias J Jabbour, Farhad Ravandi, et al.Clinical Lymphoma, Myeloma & Leukemia|July 9, 2019
Blastic Plasmacytoid Dendritic Cell Neoplasm-Current InsightsSangeetha Venugopal, Selena Zhou, Siraj M El Jamal, et al.Cancer|January 15, 2021
Phase 2 study of lenalidomide maintenance for patients with high-risk acute myeloid leukemia in remissionIman Abou Dalle, Hagop M Kantarjian, Farhad Ravandi, et al.American Journal of Hematology|June 26, 2019
Prognostic significance of baseline FLT3-ITD mutant allele level in acute myeloid leukemia treated with intensive chemotherapy with/without sorafenibFevzi Yalniz, Iman Abou Dalle, Hagop Kantarjian, et al.BBA Clinical|January 11, 2017
Hemophagocytic lymphohistiocytosis in adults: An under recognized entityAbdul Rashid Shah, Tariq Muzzafar, Rita Assi, et al.Pageof 97